Andere Sprachen Agile Therapeutics, Inc.

Aktien

A3D7A3

US00847L3087

AGRX

Markt geschlossen - OTC Markets Andere Börsenplätze 21:10:57 25.06.2024			% 5 Tage	% 1. Jan.
0,334 ^USD	+0,30 %		-1,74 %	-82,87 %

15.05.	Agile Therapeutics, Inc. meldet Ergebnis für das erste Quartal zum 31. März 2024	CI
28.03.	Transcript : Agile Therapeutics, Inc., Q4 2023 Earnings Call, Mar 28, 2024

Andere Sprachen

Schalten Sie alle Nachrichten frei: Seien Sie als Erster informiert und reagieren Sie vor den Märkten!

100% kostenlose Registrierung

AGILE THERAPEUTICS : REPORTS FIRST QUARTER 2024 FINANCIAL RESULTS AND PROVIDES CORPORATE UPDATE - Form 8-K	15.05.
Agile Therapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	15.05.
Agile Therapeutics: Q1 Earnings Snapshot	15.05.
Earnings Flash (AGRX) AGILE THERAPEUTICS Posts Q1 Revenue $5.7M	15.05.
Agile Therapeutics Reports First Quarter 2024 Financial Results and Provides Corporate Update	15.05.
Agile Therapeutics: Q4 Earnings Snapshot	28.03.
Earnings Flash (AGRX) AGILE THERAPEUTICS Posts Q4 Revenue $3.6M	28.03.
Agile Therapeutics Reports Fourth Quarter & Full Year 2023 Financial Results and Provides Corporate Update	28.03.
Agile Therapeutics, Inc. Reports Earnings Results for the Fourth Quarter Ended December 31, 2023	28.03.
Agile Therapeutics, Inc.(OTCPK:AGRX) dropped from S&P TMI Index	28.03.
Agile Therapeutics Announces Delisting from Nasdaq	25.03.
Agile Therapeutics, Inc.(OTCPK:AGRX) dropped from NASDAQ Composite Index	25.03.
North American Morning Briefing : Stocks Struggle After New Records	22.03.
Correction - Agile Therapeutics to Report Fourth Quarter and Full Year 2023 Financial Results and Provide Business Update on Thursday, March 28, 2024	21.03.
Agile Therapeutics to Report Fourth Quarter and Full Year 2023 Financial Results and Provide Business Update on Friday, March 22, 2024	20.03.
North American Morning Briefing : Stock Futures -2-	19.03.
Agile Therapeutics Inc. Completes Pay-Off the Remainder of its Debt Facility	14.03.
Agile Therapeutics Completes Pay-off of Debt and Remains Focused on Business Plan Execution	13.03.
Agile Therapeutics Announces Exercise of Warrants for $4.8 Million Gross Proceeds	22.02.
Top Premarket Gainers	22.02.

Keine Ergebnisse zu dieser Suche

Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Andere Sprachen Agile Therapeutics, Inc.

Aktien

A3D7A3

US00847L3087

AGRX

Andere Sprachen

Filter